MHC ligands and peptide motifs: first listing

Hans‐Georg Rammensee(Max Planck Institute for Biology), Stefan Stevanović(University of Tübingen)

Immunogenetics

February 1, 1995

10.1007/bf00172063

Cited by 1,650

Related Papers

Biosynthesis of the lantibiotic Pep5

|European Journal of Biochemistry|1990|106

ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS

|Neuro-Oncology|2018|26

A mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group (NOA-16).

|Journal of Clinical Oncology|2018|25